New User? Sign Up | Sign In

Insider Trading - NeuBase Therapeutics Inc. (NBSE)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

NBSE Insider Trading Transactions for NeuBase Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-04-10
Purchase
2017-04-13
11:11 am
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
142,858 $0.7 $100,001 1,649,605
(Indirect
Direct)
View
2017-04-10
Purchase
2017-04-13
12:59 pm
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
71,429 $0.7 $50,000 212,596
(Direct)
View
2017-04-10
Purchase
2017-04-13
2:45 pm
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
142,858 $0.7 $100,001 1,067,898
(Indirect
Direct)
View
2017-04-10
Purchase(A)
2017-12-06
3:41 pm
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
171,429 $0.7 $120,000 1,678,177
(Indirect
Direct)
View
2020-04-30
Purchase
2020-05-04
09:56 am
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
10,833 $6 $64,998 36,080
(Indirect
Direct)
View
2020-04-30
Purchase
2020-05-04
12:28 pm
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
1,000 $6 $6,000 11,630
(Direct)
View
2020-04-30
Purchase
2020-05-04
2:18 pm
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
10,000 $6 $60,000 10,000
(Direct)
View
2020-04-30
Purchase
2020-05-04
3:25 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
10,000 $6 $60,000 10,000
(Indirect
Direct)
View
2020-05-21
Purchase
2020-05-26
4:39 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
1,250 $8.0888 $10,111 11,250
(Indirect
Direct)
View
2020-06-09
Purchase
2020-06-10
11:50 am
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
Lipizzaner LLC
CEO
10% Owner
1,275 $7.7339 $9,861 12,525
(Indirect
Direct)
View
2021-04-26
Purchase
2021-04-27
4:01 pm
NeuBase Therapeutics Inc. NBSE Mann William Roland
COO
5,000 $5 $25,000 5,000
(Direct)
View
2021-04-26
Purchase
2021-04-27
4:02 pm
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
12,000 $5 $60,000 22,000
(Direct)
View
2021-04-26
Purchase
2021-04-27
4:03 pm
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
12,000 $5 $60,000 24,525
(Indirect
Direct)
View
2021-04-26
Purchase
2021-04-27
4:03 pm
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
5,000 $5 $25,000 41,080
(Indirect
Direct)
View
2021-06-18
Purchase
2021-06-21
11:03 am
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
8,000 $4.75 $38,000 30,000
(Direct)
View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-04-10
Purchase
2017-04-13
11:11 am
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
100,001 $0 100,001
(Direct)
View
2017-04-10
Purchase
2017-04-13
12:59 pm
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
50,001 $0 50,001
(Direct)
View
2017-04-10
Purchase
2017-04-13
2:45 pm
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
100,001 $0 100,001
(Direct)
View
2017-05-12
Option Award
2017-05-16
5:07 pm
N/A
2022-05-11
Ohr Pharmaceutical Inc OHRP Ferguson Michael
Director
750,000 $0 750,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:00 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
245,000 $0 245,000
(Direct)
View
2017-05-12
Option Award
2017-10-18
6:00 pm
N/A
2022-05-11
Ohr Pharmaceutical Inc OHRP Ferguson Michael
Director
500,000 $0 500,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:01 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Almenoff June Sherie
Director
170,000 $0 170,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:01 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Slakter Jason Scott
CEO
390,000 $0 390,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:01 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Riedhammer Thomas M
Director
170,000 $0 170,000
(Direct)
View
2017-10-16
Option Award
2017-10-18
6:02 pm
N/A
2022-10-15
Ohr Pharmaceutical Inc OHRP Backenroth Samuel
CFO
350,000 $0 350,000
(Direct)
View
2017-04-10
Purchase
2017-12-06
3:41 pm
2017-04-10
2022-04-10
Ohr Pharmaceutical Inc OHRP HIRSCHMAN ORIN
Director
120,001 $0 120,001
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:32 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
772,923 $0 772,923
(Direct)
View
2019-07-12
Other
2019-07-16
8:32 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
3,000 $0 0
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:33 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
227,330 $0 227,330
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:34 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE Miralles Gines Diego
Director
227,330 $0 227,330
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
25,247 $0 25,247
(Indirect)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
227,330 $0 227,330
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
2,547,639 $0 2,547,639
(Indirect)
View
2019-07-12
Option Award
2019-07-16
8:35 pm
2019-07-12
2028-12-31
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
3,311,930 $0 3,311,930
(Direct)
View
2019-07-12
Option Award
2019-07-16
8:36 pm
N/A
2029-07-12
NeuBase Therapeutics Inc. NBSE PRENDERGAST FRANKLYN G
Director
227,330 $0 227,330
(Direct)
View
2020-07-27
Option Award
2020-07-28
4:22 pm
N/A
2030-07-27
NeuBase Therapeutics Inc. NBSE Mann William Roland
COO
175,000 $0 175,000
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:19 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE PRENDERGAST FRANKLYN G
Director
14,634 $0 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE RICHMAN ERIC I
Director
14,634 $0 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE Miralles Gines Diego
Director
14,634 $0 14,634
(Direct)
View
2020-09-09
Option Award
2020-09-11
5:20 pm
N/A
2030-09-09
NeuBase Therapeutics Inc. NBSE GOLDSTEIN DOV A MD
Director
14,634 $0 14,634
(Direct)
View
2020-12-01
Option Award
2020-12-02
09:46 am
N/A
2030-12-01
NeuBase Therapeutics Inc. NBSE Bradshaw Curt
Chief Scientific Officer
250,000 $0 250,000
(Direct)
View
2020-12-29
Option Award
2020-12-30
5:01 pm
N/A
2030-12-29
NeuBase Therapeutics Inc. NBSE Backenroth Samuel
CFO
41,915 $0 41,915
(Direct)
View
2020-12-29
Gift
2020-12-30
5:01 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
2,547,639 $0 2,547,639
(Indirect)
View
2020-12-29
Gift
2020-12-30
5:01 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
1,273,819 $0 2,547,639
(Indirect)
View
2020-12-29
Gift
2020-12-30
5:01 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
1,273,819 $0 2,547,639
(Indirect)
View
2020-12-29
Gift
2020-12-30
5:01 pm
N/A
N/A
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
1,273,820 $0 1,273,819
(Indirect)
View
2020-12-29
Option Award
2020-12-30
5:01 pm
N/A
2030-12-29
NeuBase Therapeutics Inc. NBSE Stephan Dietrich A
CEO
10% Owner
164,925 $0 164,925
(Direct)
View
2021-05-11
Option Award
2021-05-13
6:03 pm
N/A
2031-05-11
NeuBase Therapeutics Inc. NBSE McDougall Gerald J
Director
92,219 $0 92,219
(Direct)
View
2021-05-24
Option Award
2021-05-25
4:12 pm
N/A
2031-05-24
NeuBase Therapeutics Inc. NBSE Motesharei Kianoush
See Remarks
250,000 $0 250,000
(Direct)
View
2021-05-24
Option Award
2021-05-25
4:13 pm
N/A
2031-05-24
NeuBase Therapeutics Inc. NBSE Rojas-Caro Sandra
Chief Medical Officer
280,000 $0 280,000
(Direct)
View